Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20448
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCasan, Joshua Ml-
dc.contributor.authorBarraclough, Allison-
dc.contributor.authorShortt, Jake-
dc.contributor.authorHawkes, Eliza A-
dc.date.accessioned2019-03-14T22:35:10Z-
dc.date.available2019-03-14T22:35:10Z-
dc.date.issued2019-03-
dc.identifier.citationThe Lancet. Haematology 2019; 6(3): e119en
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/20448-
dc.language.isoeng-
dc.titleDose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Lancet. Haematologyen
dc.identifier.affiliationSchool of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australiaen
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationHaematology Department, Monash Health, Melbourne, Victoria, Australiaen
dc.identifier.doi10.1016/S2352-3026(19)30013-4en
dc.type.contentTexten
dc.identifier.orcid0000-0002-0376-2559en
dc.identifier.pubmedid30824036-
dc.type.austinLetter-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptClinical Haematology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

6
checked on Feb 5, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.